Cargando…

Effect of Protease Inhibitors on Steady-State Pharmacokinetics of Oral Norethindrone Contraception in HIV-Infected Women

OBJECTIVE: Pharmacokinetic interactions exist between combined oral contraceptives and protease inhibitors (PI). However, such information is lacking for progestin-only oral contraception. We sought to define the steady-state pharmacokinetic interaction between norethindrone (NET) and PI in HIV-infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atrio, Jessica, Stanczyk, Frank Z., Neely, Michael, Cherala, Ganesh, Kovacs, Andrea, Mishell, Daniel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946363/ https://www.ncbi.nlm.nih.gov/pubmed/24025339 http://dx.doi.org/10.1097/QAI.0b013e3182a9b3f1

Ejemplares similares

Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors
por: Arkenau, Hendrik‐Tobias, et al.
Publicado: (2022)

Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial
por: Dean, Joshua, et al.
Publicado: (2019)

Norethindrone Acetate in the Medical Management of Adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012)

Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids
por: Beck, Denise, et al.
Publicado: (2021)

HT update: spotlight on estradiol/norethindrone acetate combination therapy
por: Casey, Colleen L, et al.
Publicado: (2008)

Medical management of recurrent endometrioma with long-term norethindrone acetate
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012)

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases
por: Read, William L., et al.
Publicado: (2017)

Ziritaxestat Drug–Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition
por: Helmer, Eric, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women
por: Feldman, Robert A., et al.
Publicado: (2021)

Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults
por: Townsend, Robert, et al.
Publicado: (2016)

Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
por: Min, Michelle S., et al.
Publicado: (2016)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate
por: DiVasta, Amy D., et al.
Publicado: (2021)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women
por: Pene Dumitrescu, Teodora, et al.
Publicado: (2021)

Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive
por: Zhao, Yuan, et al.
Publicado: (2020)

Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial
por: Edelman, Alison B., et al.
Publicado: (2022)

Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers
por: Cherala, Ganesh, et al.
Publicado: (2022)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol
por: Song, Ivy H., et al.
Publicado: (2015)

Differences in the pharmacokinetics and steady-state blood concentrations of orally administered lenvatinib in adult and juvenile rats
por: Du, Xiaoyue, et al.
Publicado: (2023)

Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy
por: Soliman, Ahmed M., et al.
Publicado: (2016)

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin
por: Ramachandran, Geetha, et al.
Publicado: (2012)

Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers
por: Menon, Sujatha, et al.
Publicado: (2016)

Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies?
por: Dauki, Anees M., et al.
Publicado: (2022)

The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals
por: Kehinde, Idowu, et al.
Publicado: (2019)

Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective
por: Okumura, Lucas Miyake
Publicado: (2016)

Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive
por: Hofmann, Birte, et al.
Publicado: (2014)

Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients
por: Menkes, David B., et al.
Publicado: (2017)

551. MK-8591 Does Not Alter the Pharmacokinetics of the Oral Contraceptives Ethinyl Estradiol and Levonorgestrel
por: Ankrom, Wendy, et al.
Publicado: (2018)

The effect of low-dose combined hormone therapy (oestradiol and norethindrone acetate) on serum C-reactive protein levels and life quality in natural menopause women
por: Gocer, Servin, et al.
Publicado: (2021)

Steady-state Carbamazepine Pharmacokinetics following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effect of Race and Sex
por: Marino, SE, et al.
Publicado: (2012)

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment
por: Toussi, Sima S., et al.
Publicado: (2022)

Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women
por: Trezza, Christine, et al.
Publicado: (2017)

Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility
por: Hellwig, Kerstin, et al.
Publicado: (2016)

Oral contraceptives alter oral health
por: Saini, Rajiv, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nduteoajours2m4mudf6v0ga54